Announce Date | 05/09/2025 |
EPS Normalized Actual | $0.41 (Beat by $0.26) |
EPS GAAP Actual | $0.41 (Beat by $0.26) |
Revenue Actual | $0.07882B |
Revenue Surprise | Beat by $78.82M |
Announce Date | 09/30/2025 (Pre-Market) |
EPS Normalized Estimate | $0.44897 |
EPS GAAP Estimate | $0.44897 |
Revenue Estimate | $0.236164787B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 3.09 | 7.36 | 2.87206 | 3.40848 | 1 |
Dec 2028 | 2.91 | 7.82 | 2.70425 | 3.1495 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | -0.93 | -1.11205 | 0.07882B | -96.51% | -142.64M |
FQ3 2021 (Sep 2021) | -2.77 | -2.77 | 0.229536B | 100% | 229.54M |
FQ4 2021 (Dec 2021) | 0 | 0 | 0.630873B | 100% | 630.87M |
FQ1 2022 (Mar 2022) | -2.29 | -2.29 | 0.279134B | 100% | 279.13M |
FQ2 2022 (Jun 2022) | 3.24 | 3.24 | 0.387297B | 100% | 387.3M |
FQ3 2022 (Sep 2022) | 0.88 | 0.88 | 0.573323B | 59.96% | 573.32M |
FQ4 2022 (Dec 2022) | 0 | 0 | 0.420465B | -50.04% | 420.47M |
FQ1 2023 (Mar 2023) | 1.14 | 1.14 | 0.218736B | -27.61% | 218.74M |
FQ4 Announce Date
09/30/2025 (Pre-Market)
Consensus EPS Estimates
0.44897
Consensus Revenue Estimates
0.236164787B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2028 (Sep 2028) | 0.73 | -- | 0.69592 | 0.77497 | 3 |
FQ2 2028 (Jun 2028) | 0.72 | -- | 0.68639 | 0.76436 | 3 |
FQ1 2028 (Mar 2028) | 0.7 | -- | 0.66732 | 0.74312 | 3 |
FQ3 2027 (Sep 2027) | 1.09423 | -- | 1.09423 | 1.09423 | 1 |
FQ2 2027 (Jun 2027) | 0.75237 | -- | 0.75237 | 0.75237 | 1 |
FQ1 2027 (Mar 2027) | 0.40934 | -- | 0.40934 | 0.40934 | 2 |
FQ3 2026 (Sep 2026) | 0.87892 | -- | 0.87892 | 0.87892 | 1 |
FQ2 2026 (Jun 2026) | 0.29295 | -- | 0.29295 | 0.29295 | 1 |
FQ1 2026 (Mar 2026) | 0.33419 | 378.28 | 0.33419 | 0.33419 | 2 |
FQ3 2025 (Sep 2025) | 0.44897 | -- | 0.44897 | 0.44897 | 2 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2028 (Sep 2028) | 0.27B | -- | 0.26B | 0.28B | 1 |
FQ2 2028 (Jun 2028) | 0.27B | -- | 0.26B | 0.28B | 1 |
FQ1 2028 (Mar 2028) | 0.26B | -- | 0.25B | 0.28B | 1 |
FQ3 2027 (Sep 2027) | 0.35B | -- | 0.35B | 0.35B | 2 |
FQ2 2027 (Jun 2027) | 0.32B | -- | 0.32B | 0.32B | 2 |
FQ1 2027 (Mar 2027) | 0.3B | -- | 0.3B | 0.3B | 1 |
FQ3 2026 (Sep 2026) | 0.24B | -- | 0.24B | 0.24B | 1 |
FQ2 2026 (Jun 2026) | 0.23B | -- | 0.23B | 0.23B | 1 |
FQ1 2026 (Mar 2026) | 0.25B | 68.21 | 0.25B | 0.25B | 2 |
FQ3 2025 (Sep 2025) | 0.24B | -- | 0.24B | 0.24B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
3
EPS # of Misses
3
EPS # of in-lines
2
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.18205 | -0.93 | -1.11205 | 119.58% |
FQ3 2021 (Sep 2021) | -2.77 | -2.77 | 100% | |
FQ4 2021 (Dec 2021) | 0 | 0 | NAN% | |
FQ1 2022 (Mar 2022) | -2.29 | -2.29 | 100% | |
FQ2 2022 (Jun 2022) | 3.24 | 3.24 | 100% | |
FQ3 2022 (Sep 2022) | 0.88 | 0.88 | 100% | |
FQ4 2022 (Dec 2022) | 0 | 0 | NAN% | |
FQ1 2023 (Mar 2023) | 1.14 | 1.14 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0.22B | $0.08B | $-142.64M | -180.97% |
FQ3 2021 (Sep 2021) | $0B | $0.23B | $229.54M | 100% |
FQ4 2021 (Dec 2021) | $0B | $0.63B | $630.87M | 100% |
FQ1 2022 (Mar 2022) | $0B | $0.28B | $279.13M | 100% |
FQ2 2022 (Jun 2022) | $0B | $0.39B | $387.3M | 100% |
FQ3 2022 (Sep 2022) | $0B | $0.57B | $573.32M | 100% |
FQ4 2022 (Dec 2022) | $0B | $0.42B | $420.47M | 100% |
FQ1 2023 (Mar 2023) | $0B | $0.22B | $218.74M | 100% |